Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 12, 2025 04:00 ET | Source: AKAMPION

Thermosome Receives U.S. Orphan Drug Designation for Lead Compound THE001, Expands Patent Estate

ODD granted for the treatment of soft tissue sarcomas (STS)Thermosome adds 4 patents to its growing patent estate Munich, Germany – May 12, 2025 – Thermosome, a drug development company focused on...
December 04, 2024 04:00 ET | Source: AKAMPION

Thermosome Initiates Final Dose Level in Phase I Trial of Lead Compound THE001

Independent Data Safety Monitoring Board declared dose level 2 as safe and recommended escalation to ﬁnal dose level 3 Munich, Germany – December 4, 2024 – Thermosome, a drug development company...
February 06, 2024 04:00 ET | Source: AKAMPION

Thermosome Announces Further Dose Escalation in Phase I Trial with Lead Program THE001

- First dose level rated as safe by independent Data Safety Monitoring Board- Second dose level to be administered according to plan- THE001 designed as targeted tumor treatment independent...